191 related articles for article (PubMed ID: 29150341)
1. Increased prevalence of clinical and subclinical atherosclerosis in patients with damaging mutations in ABCA1 or APOA1.
Abdel-Razek O; Sadananda SN; Li X; Cermakova L; Frohlich J; Brunham LR
J Clin Lipidol; 2018; 12(1):116-121. PubMed ID: 29150341
[TBL] [Abstract][Full Text] [Related]
2. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.
He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Sean Davidson W; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
Circulation; 2024 Mar; 149(10):774-787. PubMed ID: 38018436
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of coronary artery disease in Caucasians with extremely low HDL cholesterol due to mutations in ABCA1, APOA1, and LCAT.
Tietjen I; Hovingh GK; Singaraja R; Radomski C; McEwen J; Chan E; Mattice M; Legendre A; Kastelein JJ; Hayden MR
Biochim Biophys Acta; 2012 Mar; 1821(3):416-24. PubMed ID: 21875686
[TBL] [Abstract][Full Text] [Related]
4. Treatment of low HDL-C subjects with the CETP modulator dalcetrapib increases plasma campesterol only in those without ABCA1 and/or ApoA1 mutations.
Niesor EJ; Kallend D; Bentley D; Kastelein JJ; Kees Hovingh G; Stroes ES
Lipids; 2014 Dec; 49(12):1245-9. PubMed ID: 25281277
[TBL] [Abstract][Full Text] [Related]
5. Premature atherosclerosis, extremely low HDL-cholesterol and concurrent defects in APOA1 and ABCA1 genes: a family case report.
Koopal C; Visseren FL; Kastelein JJ; Westerink J
Int J Cardiol; 2014 Nov; 177(1):e19-21. PubMed ID: 25127959
[No Abstract] [Full Text] [Related]
6. Gene-gene combination effect and interactions among ABCA1, APOA1, SR-B1, and CETP polymorphisms for serum high-density lipoprotein-cholesterol in the Japanese population.
Nakamura A; Niimura H; Kuwabara K; Takezaki T; Morita E; Wakai K; Hamajima N; Nishida Y; Turin TC; Suzuki S; Ohnaka K; Uemura H; Ozaki E; Hosono S; Mikami H; Kubo M; Tanaka H
PLoS One; 2013; 8(12):e82046. PubMed ID: 24376512
[TBL] [Abstract][Full Text] [Related]
7. Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy.
Lutucuta S; Ballantyne CM; Elghannam H; Gotto AM; Marian AJ
Circ Res; 2001 May; 88(9):969-73. PubMed ID: 11349008
[TBL] [Abstract][Full Text] [Related]
8. Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels.
Villard EF; EI Khoury P; Frisdal E; Bruckert E; Clement K; Bonnefont-Rousselot D; Bittar R; Le Goff W; Guerin M
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):822-8. PubMed ID: 23372063
[TBL] [Abstract][Full Text] [Related]
9. TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis.
Lake NJ; Taylor RL; Trahair H; Harikrishnan KN; Curran JE; Almeida M; Kulkarni H; Mukhamedova N; Hoang A; Low H; Murphy AJ; Johnson MP; Dyer TD; Mahaney MC; Göring HHH; Moses EK; Sviridov D; Blangero J; Jowett JBM; Bozaoglu K
Eur Heart J; 2017 Dec; 38(48):3579-3587. PubMed ID: 28655204
[TBL] [Abstract][Full Text] [Related]
10. A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla).
Pisciotta L; Vitali C; Favari E; Fossa P; Adorni MP; Leone D; Artom N; Fresa R; Calabresi L; Calandra S; Bertolini S
J Clin Lipidol; 2015; 9(6):837-846. PubMed ID: 26687706
[TBL] [Abstract][Full Text] [Related]
11. Genetic and secondary causes of severe HDL deficiency and cardiovascular disease.
Geller AS; Polisecki EY; Diffenderfer MR; Asztalos BF; Karathanasis SK; Hegele RA; Schaefer EJ
J Lipid Res; 2018 Dec; 59(12):2421-2435. PubMed ID: 30333156
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol.
Candini C; Schimmel AW; Peter J; Bochem AE; Holleboom AG; Vergeer M; Dullaart RP; Dallinga-Thie GM; Hovingh GK; Khoo KL; Fasano T; Bocchi L; Calandra S; Kuivenhoven JA; Motazacker MM
Atherosclerosis; 2010 Dec; 213(2):492-8. PubMed ID: 20880529
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
[TBL] [Abstract][Full Text] [Related]
14. Genotypic variation in ATP-binding cassette transporter-1 (ABCA1) as contributors to the high and low high-density lipoprotein-cholesterol (HDL-C) phenotype.
Mantaring M; Rhyne J; Ho Hong S; Miller M
Transl Res; 2007 Apr; 149(4):205-10. PubMed ID: 17383594
[TBL] [Abstract][Full Text] [Related]
15. Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis.
Brunham LR; Singaraja RR; Hayden MR
Annu Rev Nutr; 2006; 26():105-29. PubMed ID: 16704350
[TBL] [Abstract][Full Text] [Related]
16. Mutations in APOA-I and ABCA1 in Norwegians with low levels of HDL cholesterol.
Berge KE; Leren TP
Clin Chim Acta; 2010 Dec; 411(23-24):2019-23. PubMed ID: 20800056
[TBL] [Abstract][Full Text] [Related]
17. PI(4,5)P2 Is Translocated by ABCA1 to the Cell Surface Where It Mediates Apolipoprotein A1 Binding and Nascent HDL Assembly.
Gulshan K; Brubaker G; Conger H; Wang S; Zhang R; Hazen SL; Smith JD
Circ Res; 2016 Sep; 119(7):827-38. PubMed ID: 27514935
[TBL] [Abstract][Full Text] [Related]
18. HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function.
Berisha SZ; Brubaker G; Kasumov T; Hung KT; DiBello PM; Huang Y; Li L; Willard B; Pollard KA; Nagy LE; Hazen SL; Smith JD
J Lipid Res; 2015 Mar; 56(3):653-664. PubMed ID: 25561462
[TBL] [Abstract][Full Text] [Related]
19. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
[TBL] [Abstract][Full Text] [Related]
20. Genetic etiology of isolated low HDL syndrome: incidence and heterogeneity of efflux defects.
Kiss RS; Kavaslar N; Okuhira K; Freeman MW; Walter S; Milne RW; McPherson R; Marcel YL
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1139-45. PubMed ID: 17303779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
